KIPLOKS ROBUSTNESS ENGINE
We break strategies before real money does.

Backtests show performance.
Kiploks shows survivability.

Can this strategy survive real capital?

Most tools show how good a strategy looks.

Kiploks shows how easily it breaks.

  • • robustness across time
  • • overfitting probability
  • • parameter fragility
  • • capital failure thresholds
Before money is deployed.

Kiploks is a strategy robustness engine for trading strategy testing and to stress test trading strategies before live deployment.

Unlike backtesting tools, it delivers algorithmic strategy risk analysis and trading bot robustness assessment: walk-forward efficiency, parameter fragility, and capital failure thresholds.

What Kiploks Actually Does

Kiploks is NOT:

• a signal generator

• an optimizer

• a backtest visualizer

Kiploks IS:

• Trading strategy testing for robustness to real markets

• Stress-testing algorithms before real capital

• Risk and stability assessment of strategies — not just a backtest

If a strategy fails here, it fails before real money.

Core Questions (this is where people nod)

Real trading strategy testing and stress test questions:

  • • Does this strategy survive out-of-sample?
  • • Which parameters are fragile?
  • • What market regimes break it?
  • • How much capital degrades the edge?
  • • Is performance driven by luck or structure?

Most platforms never answer these. Kiploks gives you algorithmic strategy risk analysis and robustness assessment.

Kiploks does.

Used by systematic traders, quant, and bot and backtest builders

to validate strategies before capital deployment.

Robustness analysis

Detect overfitting, fragility, and regime dependence.

  • • Walk-forward validation
  • • Parameter sensitivity
  • • Market regime robustness
  • • Monte Carlo stability

Decision engine

Explainable verdicts instead of metric dumps.

  • ROBUST / CAUTION / DO NOT DEPLOY
  • • Confidence scoring
  • • Risk classification
  • • Actionable warnings

Scalable Research

Scale research without losing reproducibility.

  • • Parallel execution
  • • Result deduplication
  • • Cache reuse
  • • Audit-friendly outputs

Decision Engine Flow

TESTS

  • • Out-of-sample decay
  • • Parameter instability
  • • Monte Carlo tail risk
  • • Regime failure detection
  • • Capital stress & capacity limits

VERDICT

ROBUST
CAUTION
DO NOT DEPLOY

Kiploks Analytics
at a glance

Analysis below is created from real backtest data. Mixed outcome - some strong metrics, some weak.

Final Verdict Summary

One screen answers the main question: launch the strategy now, wait, or drop it.

  • Verdict - ROBUST (solid), CAUTION (needs attention), or DO NOT DEPLOY (not ready)
  • Robustness score and chance of success - how reliable the strategy looks
  • Checklist - did it pass validation, risk and cost checks? Green means you can consider deploying
  • Short summary: what works, what fails, and what we recommend doing next
  • Optional What-If table - see how the verdict changes if you tweak key numbers

[Methodology: Final Verdict Summary]

FINAL VERDICT

DO NOT DEPLOY

Diagnostic case: Neutral / Incubate (© Kiploks)

Kiploks Robustness Score: 0 / 100Bayesian pass probability: 38%

One or more hard gates failed. DO NOT DEPLOY until blocking modules are fixed.

Deployment Gate
Validation Gates
  • Execution Buffer - Net Edge (Net Profit > 15 bps, period-level)(-32.51 bps vs 15 bps) ESTIMATED - Net edge below 15 bps or edge deficit after fees
  • Stability (WFE > 0.5)(1.26 vs 0.5)
  • Data Quality Guard (test period ≥ 2 years)(769 vs 730 days)
Statistical Confidence
  • Statistical Significance (t-Stat > 1.96)
  • t-Stat (OOS Edge) > 2.0 (same metric as above, stricter threshold)(-1.19 vs 2) - t-Stat below 2.0 (OOS edge not significant). Same metric as Statistical Significance; 2.0 is stricter than 1.96. Single OOS window - interpret with caution.
Critical Failures
  • Deployment is blocked because the following hard gate(s) failed: Execution Buffer - Net Edge (Net Profit > 15 bps, period-level).
Execution Note: Backtest execution settings were missing. The system applied a standard Safety Buffer (0.05% slippage, 0.1% fee). For Institutional Grade (AAA), provide exact exchange API fees and liquidity-based slippage. You can set slippage and commission in your backtest or integration config to use exact values and remove this note.
Operational Insight: Net edge is negative; no slippage headroom. Status: Edge Deficit.

Robustness score is 0 because a module blocks (e.g. Risk, Execution, or Stability). Potential score if unblocked: 3. Fix blocking modules first. Even unblocked, score remains in TRASH range (0-20) - no meaningful improvement.

Kiploks Robustness Score

One number from 0 to 100 that shows how solid the strategy is. It is built from four parts:

  • Validation (40%) - does the edge hold when we test it on data the strategy has not seen?
  • Risk (30%) - reward vs risk, how deep drawdowns go, how well the strategy recovers
  • Stability (20%) - small changes in settings do not break the strategy
  • Execution (10%) - after real costs (fees, slippage), the edge is still there

If any critical part fails, the overall score can drop to 0 - one weak link affects the whole result.

A decent score still leaves room to improve on stability and execution after costs; the higher the score, the more robust the strategy.

[Methodology: Kiploks Robustness Score]

ROBUSTNESS SCORE

Formula (multiplicative penalties)
0 / 100 (FAIL)
Blocked by Walk-Forward & OOS, Risk Profile, Execution Realism modules

Diagnosis

Execution score (5/100) is below the blocking threshold of 10. Edge does not survive 10 bps slippage - strategy may not be realizable in live conditions. Review transaction costs, reduce turnover, or improve edge.

░░░░░░░░░░░░░░░░░░░░
Methodology Note[?]
Breakdown (contributing factors)
Data Quality Guard
████████████
100
→ Adequate data period for full audit
Walk-Forward & OOS(40%)(blocking)
░░░░░░░░░░░░
0
→ BLOCKED
Risk Profile(30%)(blocking)
░░░░░░░░░░░░
0
→ BLOCKED
Parameter Stability(20%)
█████████░░░
75
→ Parameters stable across sensitivity tests
Execution Realism(10%)(blocking)
░░░░░░░░░░░░
0
→ BLOCKED (raw 5, threshold 10)

Data Quality Guard

Checks that the data and run used for the analysis are trustworthy before we score robustness.

  • Sampling - enough trades for reliable stats
  • Gap density / price integrity - when OHLCV is available, checks for gaps and price sanity
  • Verdict - PASS, FAIL, or REJECT; contribution to the overall score (e.g. 0-40 points)

If DQG fails or is rejected, the analysis may be blocked or flagged so you do not rely on weak data.

[Methodology: Data Quality Guard]

DATA QUALITY GUARD

Data Quality Guard (DQG)
Score: 100%PASSDQG Factor: 1.00Contribution: 40.0

Robust Net Edge (Safe Edge): No net profit - outlier check N/A

ModuleScoreVerdict
Gap Density100%PASS
Outlier Influencen/aN/A
Look-Ahead Bias100%PASS
Spread/Liquidity100%PASS
Sampling & Over-fitting100%PASS
Price Integrity100%PASS

Walk-Forward Validation

We tune the strategy on one time window, then check how it performs on the next one - so we see if the edge is real or just overfit to past data.

  • Walk-forward efficiency - how much of the tuned performance carries over to the validation period
  • Consistency - what share of validation windows are profitable
  • Degradation - how much results drop from the tune period to the validation period
  • Failed windows - how many periods lose money; many failures suggest overfitting

Charts show how equity evolves in tune vs validation, and returns per period. Final verdict: PASS or FAIL, with a short explanation.

[Methodology: Walk-Forward Validation]

WALK-FORWARD VALIDATION

Time Stability & Overfitting Control
Performance Transfer
In-Sample (IS) vs Out-of-Sample (OOS)

Walk-Forward Analysis — Continuous View

IS (In-Sample) + OOS (Out-of-Sample) equity on a single timeline

Total OOS Return
-2012.3%
OOS Win Rate
2 / 6
IS Avg Return
-163.9%
OOS Avg Return
-194.9%
Overfitting Score
MEDIUM
Equity Curve — IS vs OOS segments (continuous)
1.030.980.940.890.840.79
ISOOS GoodOOS FragileOOS Failed
OOS performance per period (bar)
P1-101.1%-400.0%P2184.6%232.8%P393.2%288.8%P4-467.8%-398.7%P5122.6%-489.9%P6-815.0%-402.6%8%0-8%
ISOOS
WFE (Efficiency):
1.26
Consistency:
67% (2/3)
Performance Degradation:
-18.9%
Failed Windows:4 / 6
Consistency uses only windows with IS > 0. Failed Windows = windows with OOS ≤ 0 or insufficient OOS trades (in some, OOS may still be better than IS). Different denominators.
Overfitting Risk:MEDIUM (n/a)
When failure rate > 30%, overfitting risk may be understated; consider verdict and failure rate.
Professional WFA
Grade:BBB - RESEARCH ONLY(override: Verdict FAIL and failure rate > 30%; grade capped to BBB - RESEARCH ONLY.)
Research only. Do not deploy to production without further validation.
Pre-verdict module scores (composite; overall verdict and grade above)
WFE Advanced: ROBUST(score 94)(pre-verdict composite; overall verdict FAIL)
Overall verdict FAIL - do not rely on this score alone.
Regime: STABLE
Monte Carlo: DOUBTFUL(P(positive)=9%)
Stress: RESILIENT(recovery: HIGH)
Equity curve: WEAK
Window Breakdown
Inst Insights
Performance degradation (aggregate over all windows) is significant.
Failure rate exceeds 30% of windows.
Data Provenance
Source: research.results
Heavy status: loaded
Heavy ref: loaded
R2 public URL: loaded
Points per curve: 100
Total Trades per Period: Period 1: 10, Period 2: 7, Period 3: 8, Period 4: 10, Period 5: 8, Period 6: 10
Param Drift: n/a
Report generated at: 2026-02-26T14:31:07.293Z
Failed Windows Details
• Period 1: Validation return is non-positive
• Period 4: Validation return is non-positive
• Period 5: Validation return is non-positive
• Period 6: Validation return is non-positive
Failed Windows Context:
No regime data available
▶ Verdict: FAIL
Failure rate exceeds 30% - verdict forced to FAIL.

Benchmark Metrics

Summary of how well the strategy holds up when tested on data it was not tuned on.

  • Walk-forward efficiency - how much of the optimized edge carries over to the next period (min, typical, max)
  • Out-of-sample - average risk-adjusted returns, how often it stays profitable, chance of passing
  • Kill-switch - how many bad periods in a row before we flag a problem
  • Stability - how stable the edge is over time
  • Regimes - how the strategy behaves in different market conditions (trend, range, high volatility)

Benchmark Metrics Verdict: READY, INCUBATE, CAUTION, or REJECT, plus a short summary of what it means.

[Methodology: Benchmark Metrics]

BENCHMARK METRICS

Quick Win (WFA summary)
OOS Sharpe: -0.60(same as below)OOS Calmar: -0.16OOS Max DD (validation only): -12.37%
WFE (Median OOS/IS): 1.26 (N=3 of 6, IS>0 only)Relative Loss Magnitude: 119.0%
Full Sharpe: -0.04Full Calmar: -0.38
Profitable Windows[?]2/6 all windows (33%) FAIL
Profitable OOS among IS>0 windows(same base as WFE)2/3
OOS/IS Trend MatchYES
Win Rate Change (OOS − IS, pp)[?]-5.4 pp RED FLAG
IS Win Rate / OOS Win Rate88.4% / 83.0%
IS: full backtest; OOS: OOS trades
Statistical Robustness (OOS Validation)
WFE (Median OOS/IS) distribution
min-4.00|median1.26|max3.10scale
WFE Variance9.036(population)(Consistency: Low)
Parameter Stability Index (PSI)[?]n/a[?]
Edge Half-Life (T1/2, OOS)[?]n/a[?]
WFA Windows6
Exp. OOS Return ± Vol[?]-1.9% ± 3.2%
Worst Window Return (N=6, 1 obs)[?]
-4.90%
Avg OOS Sharpe (window-level)[?]-0.60
Avg OOS Calmar (approx)[?]-0.16
Optimization Gain (IS)[?]1.86%
Relative Loss Magnitude (OOS/IS)[?]119.0%(N=6 windows)
Relative Change (OOS−IS)/|IS|(mean OOS vs mean IS)[?]-19.0%
Advanced Diagnostic Indicators
OOS Dominance Ratio (OOS > 90% of IS)[?]66.7%
Estimated pass probability[?]38%
Capital Kill Switch (OOS fail windows tolerated)3 consecutive (all windows) (limit: 1)
Capital Kill Switch checklist
CheckStatusThresholdCurrentRelative Loss Magnituden/a≥ 20%119.0%Net Edge Safety(market-relative)(i)FAIL≥ 10 bps-32.51 bpsRegime AdaptabilityFAIL≥ 1/3 pass0/3 passBayesian ConfidenceFAIL≥ 65%38%
Strategy Class FingerprintRegime-dependent
Regime Survival Matrix0/3 pass
Market Bias: Sideways - explains why some regime cells are n/a
Trendn/a
RangeFragile
HighVoln/a
Verdict[?]
🔴REJECT

Immediate Kill Switch triggered. Net Edge < 10 bps (current: -32.51 bps); Bayesian pass probability < 65% (current: 38%); Regime adaptability: 0/3 pass (min 1); Consecutive OOS drawdown windows: 3 (limit: 1)

Capital Kill Switch - The Red Line[?]
3 consecutive (all windows) (limit: 1)

Next OOS window in minus → turn off bot

Benchmark Comparison

How your strategy stacks up against BTC buy and hold: same period, same risk lens.

  • Growth rate (CAGR) - strategy vs benchmark
  • Alpha - how much extra return you get over the benchmark
  • Information ratio - excess return per unit of extra risk
  • Correlation to BTC - how closely the strategy tracks the benchmark (diversification vs clone)

[Methodology: Benchmark Comparison]

BENCHMARK COMPARISON

Relative performance, risk profile, and portfolio fit vs BTC Buy & Hold.
Executive Summary
MetricStrategyBTC Buy & HoldExcess / Comment
CAGR
-9.51%27.03%-28.76% (Alpha)
Alpha (Excess CAGR)(Same as Excess CAGR)
-28.76%n/aBenchmark-relative edge
Annualized Volatility
12.60%48.88%Risk dispersion (annualized)
Risk Profile
MetricStrategyBTC Buy & HoldExcess / Comment
Max Drawdown (full backtest)
25.04%50.08%Peak-to-trough decline over whole curve
Calmar Ratio
-0.380.54Drawdown-adjusted return
Skewness
n/a[?]0.00Tail asymmetry
Kurtosis
n/a[?]9.39Tail thickness
Portfolio Fit
MetricStrategyBTC Buy & HoldExcess / Comment
Beta to BTC
0.001.00Sensitivity to BTC
Correlation to BTC
0.021.00Diversification signal
Tracking Error
50.27%Relative volatility
Rolling 30D Correlation (Peak)
0.24Stress correlation
Operational Details
MetricStrategyExcess / Comment
Fees (est.)
0.11%Per trade assumption
Slippage (est.)
0.05%[?]Per trade assumption
Break-even Slippage
n/a[?]Max slippage before alpha = 0
Net Edge (per period, bps)
-32.51(Negative edge due to costs (Scalping hell))Mean excess per period minus costs
Alpha t-Stat
n/a[?]Significance check
Key Takeaway
Insufficient data for alpha conclusion (t-Stat n/a or fewer than 30 period returns). Do not rely on alpha.
Benchmark-relative alpha is negative (-28.76%).
Risk profile: 12.60% annualized volatility.
Strategy max drawdown 25.04% vs BTC 50.08%.
Portfolio fit: beta 0.00, correlation 0.02.
Tracking error 50.27%.

Parameter Sensitivity & Stability

For each strategy setting: how sensitive it is - can you nudge it a bit without killing performance, or is it fragile?

  • Table: best value, how far you can move it and still keep most of the edge, sensitivity, and a label - Stable, Reliable, Needs Tuning, or Fragile
  • Governance - rules per parameter (e.g. time decay, liquidity limits, bounds, or only in certain market regimes)
  • Diagnostics - stability over time, safety margin, how much performance drops when you move the param, signal strength

Parameter Sensitivity & Stability Deployment status: APPROVED, APPROVED (Conditional), REJECTED, or HOLD - plus overall parameter risk and which setting is the most sensitive.

[Methodology: Parameter Sensitivity & Stability]

PARAMETER SENSITIVITY & STABILITY

Methodology: Sensitivity = R² (correlation²) between parameter value and trial score; we use it as a proxy for 'outcome strongly tied to parameter' (tuning matters). High R² = parameter significantly predicts outcome. Magnitude (slope per unit change) is a separate planned metric; Risk Score does not use slope. Sensitivity values: 2 decimal places. Risk Score: integer (floor). From optimization trials or WFA windows.
Suggested Mitigation: Risk Neutral
Parameter
Optimal[?]
Topology[?]
Sensitivity
Status
Buy_rsi
42
0.29
🟢 Stable
Suggested Mitigation: Risk Neutral
Exit_short_rsi
22
0.06
🟢 Stable
Suggested Mitigation: Risk Neutral
Roi_p1
0.03
0.01
🟢 Stable
Suggested Mitigation: Risk Neutral
Roi_p2
0.07
0.01
🟢 Stable
Suggested Mitigation: Risk Neutral
Roi_p3
0.07
0
🟢 Stable
Suggested Mitigation: Risk Neutral
Roi_t1
87
0
🟢 Stable
Suggested Mitigation: Risk Neutral
Roi_t2
44
0.02
🟢 Stable
Suggested Mitigation: Risk Neutral
Roi_t3
17
0.01
🟢 Stable
Suggested Mitigation: Risk Neutral
Sell_rsi
95
0.01
🟢 Stable
Suggested Mitigation: Risk Neutral
Short_rsi
89
0.01
🟢 Stable
Suggested Mitigation: Risk Neutral
Stoploss
-0.30
0.01
🟢 Stable
Suggested Mitigation: Risk Neutral
Scale (classification bands): Scale: round sensitivity to 2 decimals, then band. Stable [0, 0.30); Reliable [0.30, 0.40); Needs Tuning [0.40, 0.60); Fragile >= 0.6. Boundaries: 0.30 = Reliable (start); 0.40 = Needs Tuning (start); 0.60 = Fragile (start). penalisedCount = params with rounded sensitivity>= 0.4. Penalty: 2 per Needs Tuning, 5 per Fragile. Ceiling = 100 − 5×penalisedCount. Final = max(0, floor(min(Raw, ceiling))). Order: round → band → penalisedCount → Base → Penalty → Raw → Ceiling → Final. Score: integer (floor).
Sensitivity (R²): strength of linear relationship between parameter value and score (predictability), not magnitude of effect. Slope (impact per unit change) is a separate planned metric; Risk Score uses R² only. From optimization trials or WFA windows.
Topology (when available): curve shape from trials; flat = stable, sharp peak = fragile.
Sensitivity: implemented as R² (correlation²). R² measures strength of linear relationship (predictability), not magnitude of change; we use it as proxy for parameter-outcome tie (high R² = fragility). For true sensitivity (magnitude per unit parameter), derivative-based metric is planned. Values: 2 decimals; Risk Score: integer (floor).
DIAGNOSTIC SUMMARY
1. Local Topology & Stability[?]
2. Governance Impact (Suggested Mitigation)[?]
Governance metrics below do not affect Risk Score or Deployment; advisory only.
Signal Attenuation: 17.0%
Sharpe Retention (IS ➔ OOS): [?]131.3%(OOS > IS; may indicate sample or regime bias - interpret with caution)
Sharpe Drift (OOS vs IS): [?]31.3 p.p.(OOS Sharpe > IS, improvement)
Max Tail-Risk Reduction: [?]40.2%(Risk Reduced)
3. Multi-Parameter Coupling[?]
Coupling analysis: No dominant unstable interactions detected.
AUDIT VERDICT
Deployment Status: APPROVED (no Decay check)Approval does not include the Decay gate (Decay N/A). Enable HOLD_WHEN_DECAY_UNAVAILABLE to require Decay before APPROVED.
Performance Decay: N/A (min 3 periods required for decay check). When N/A, Decay condition is omitted; HOLD_WHEN_DECAY_UNAVAILABLE (backend) can force HOLD instead of APPROVED.Warning: Decay N/A and Fail-Safe is off; deployment not based on decay.
Final Decision = (Risk Score Verdict) AND (Performance Decay < 80% when Decay is defined; when Decay is N/A this condition is omitted) AND (Min OOS Trades met). REJECTED when any applied condition fails. Performance Decay is a deployment gate (step 2). Governance (Sharpe Drift, Tail-Risk, etc.) is advisory only; does not change the result.
Risk Score: [?]Base 71 − Penalty 0 → Risk Class: LOW (71/100) (passing)
Pro-Note: Highest sensitivity: Buy_rsi (0.29, Stable).

Trading Intensity & Cost Drag

How often the strategy trades, what costs eat into returns, how much size it can handle, and how execution quality affects results.

  • Baseline: how much you trade per year, trades per month, typical holding time
  • Efficiency: profit before vs after costs, how much cost eats the edge, average net profit per trade
  • Break-even slippage: how much worse execution you can tolerate before the edge disappears, and what happens if you exceed it
  • Cost breakdown: fees, slippage, market impact, total drag on returns, any rebates
  • Capacity: how much capital the strategy can run before returns start to drop (e.g. -10%, -25%) or collapse; usage of daily volume
  • Slippage vs size: how net returns change as you scale up and slippage grows
  • Execution quality: order types, fill rates, opportunity cost, and risks from latency or toxic flow

[Methodology: Trading Intensity & Cost Drag]

TRADING INTENSITY & COST DRAG

Execution: Simple (estimated fees)

Results use estimated fees/slippage. Provide exact exchange parameters for Institutional-grade analysis.
Position velocity (holding-period) (121.1x) is 3.87x institutional turnover (31.3x). Overlapping positions likely; institutional turnover is used for cost and rebate.
Market Impact (Layer 2.5)
  • ADV $171.371 is very low; model assumptions may not hold.
INTERPRETIVE SUMMARY
Period gross is negative (profit factor < 1) but per-trade gross is positive. Strategy loses at calendar level; accumulated costs exceed profit. Required Alpha Boost is execution offset only.
Baseline AUM:$1,000
Avg Trades / Month:9
Annual Turnover (institutional):[?]31.3x
Position velocity (holding-period)[?]121.1x
Avg Holding Time:[?]44.4h
Avg position size[?]61.3% of AUM
Cross-check (trades × utilization)[?]~62.6x
Implied overlap factor[?]3.87x
EFFICIENCY & COST LIMITS
Profit Factor (Gross, full backtest):[?]0.84
Profit Factor (Net, full backtest):0.76
Cost / Edge Ratio:[?]n/a (negative gross edge)
Avg Net Profit / Trade (bps)[?]-14.42 bps
Break-even Slippage:
Tolerance:n/a (negative edge)
Margin of Safety:n/a
Safety Margin:[?]n/a (negative edge)
BES Status:EDGE DEFICIT
Failure Mode:Negative period Net Edge (cost > profit)
COST DECOMPOSITION (CAGR)
Exchange Fees:-12.5%
Slippage:-6.3%
Market Impact (est.)[?]N/A - participation ratio too high for model

Participation ratio exceeds 15% of ADV; square-root model out of range.

Total Cost Drag:-18.8%

Market impact not included (model out of range); total is fees + slippage only.

Rebate Capture:0.48 bps/trade(≈ 0.15% CAGR at current turnover)

Rebate Capture is not included in Total Cost Drag; informational (potential savings with maker-heavy execution).

When gross edge is negative, cost decomposition shows cost allocation; improving execution alone cannot make the strategy profitable.

CAPACITY & MARKET IMPACT
Estimated AUM Capacity:
N/A — model out of range (participation > 15% ADV)
ADV Utilization:
Top 5 traded pairs:n/a
Portfolio weighted:n/a
Market Impact Model:
Assumption:Square-root law
Liquidity regime:Micro / low liquidity
SLIPPAGE SENSITIVITY (NON-LINEAR)
AUM Size
Slippage CAGR
Net CAGR
~$100k[N/A]
N/A
N/A
~$1.0M[N/A]
N/A
N/A
~$5.0M[N/A]
N/A
N/A
~$10.0M[N/A]
N/A
N/A
EXECUTION HARDENING
Order Type Bias:Limit-biased
Taker / Maker Ratio:40 / 60
Limit Fill Probability:69.0%
Opportunity Cost (Fill Decay):4.80 bps
Adverse Selection (Cost):1.00 bps
Latency Sensitivity:Low
Toxic Flow Risk:Low
HFT adverse selection not detected.
SENSITIVITY TO ALPHA DECAY
Alpha Half-Life:[?]720.0 days

Long half-life from WFA validation; high-turnover strategies may have shorter effective decay in practice.

Win Rate Sensitivity:[?]n/a (not meaningful)
RISK & CONTROLS
Primary Constraint:Gross edge negative (alpha-deficit)
Gross edge (per trade, at institutional 31.3x):[?]+45.6 bps

High value reflects low institutional turnover denominator; most capital cost is in overlap periods.

Gross edge (period/CAGR):[?]negative
Available Control Levers:
Reduce trading frequencyLow
Increase entry threshold (signal strength)Low
Shift to maker-only executionLow
STATUS
Deployment Class:Micro-cap / Research-only
COST ADAPTABILITY:❌ FAIL (Required: +14.4 bps)
Required Alpha Boost (bps per trade)[?]14.42 bps
CAPACITY GOVERNANCE:⚠ SCALE-LIMITED
EXECUTION RISK:CONTROLLED
Confidence Level:Low
9 trades/mo, low signal-to-noise. Negative Z suggests loss-making; low confidence (small sample).
Z-Score: -1.54(negative = loss-making tendency; low confidence (small sample). Indicative only; statistical significance not claimed at this n.)

Strategy Action Plan

Concrete next steps based on the analysis: what to fix first, how much slippage you can afford, and whether the strategy is ready to deploy.

  • Action items - prioritised by impact (e.g. parameter tuning, execution, risk)
  • Slippage tolerance - safe vs dangerous levels
  • Deployment readiness - go / wait / fix before deploying

[Methodology: Strategy Action Plan]

STRATEGY ACTION PLAN

Slippage Sensitivity Analysis
Strategy not viable — slippage sensitivity table suppressed (negative base Sharpe).

Baseline Sharpe: from WFA OOS (window-level).

WFE 1.26 (biased, n=3) / WFE 0.00 (all windows, n=6)

Equity erodes as slippage increases.

The Decision Engine
Phase 1: NOT VIABLE
  • Allocation: 0% - strategy not viable (negative base Sharpe). Do not allocate.
  • Monitoring: Observation without capital. Track Buy_rsi to detect when OOS Sharpe becomes positive.
  • Runtime Kill Switch: TRIGGERED
Kill Switch Reset Conditions (ALL must be met):
  • OOS Sharpe > 0 across minimum 2 consecutive windows
  • Fail ratio drops below 33%
  • WFE (all windows) above Phase 2 threshold for this strategy
  • Manual review by risk manager
Phase 2: UNAVAILABLE

Strategy did not pass Phase 1 (NOT VIABLE). Phase 2 conditions do not apply until base Sharpe is positive.

Conflict A (Critical)

Conflict A (Critical): Fail ratio > 50% (67% windows failed). Use pessimistic scenario; Phase 2 not applicable.

Why This Works
Bull Case

Bull Case: N/A - strategy not valid (negative base Sharpe).

Bear Case (Risks)
  • OOS retention may reflect a single regime; 0/3 regimes pass - strategy not validated across market conditions
Recommended Fixes
  • Statistical Significance: Extend test by +2 years or add instruments with low cross-correlation (ρ < 0.3) to generate independent observations. Correlated instruments share the same market regime and do not increase effective sample size.(High)

Risk Metrics (Out-of-Sample)

Risk measured on data the strategy was not tuned on: drawdowns, reward-to-risk ratios, and how stable the edge looks.

  • Key metrics: worst peak-to-trough drop, how fast it recovers, risk-adjusted returns (Sharpe, Sortino), profit factor, gain vs pain, win rate; also worst-case loss at 95% and expected shortfall in bad tails
  • Distribution: how reliable the edge is statistically, skew (asymmetry of returns), fat tails, and tail ratio
  • Narratives (optional): market context, tail risk profile, where risk comes from, stability over time

Verdict (e.g. CAUTIOUS PASS) with a split by performance, sample size, and tail risk. Recommendation: status, what to do next, max leverage. Risk assessment: STABLE, CAUTION, or UNSTABLE, plus a capacity estimate.

[Methodology: Risk Metrics (Out-of-Sample)]

RISK METRICS (OUT-OF-SAMPLE)

Out-of-sample risk metrics from Walk-Forward Analysis (stitched OOS equity curve or window returns).

Max Drawdown[?]36.61%
|
Recovery Factor[?]-0.90
Sharpe Ratio (OOS)[?]-0.16
|
Sortino Ratio[?]n/a[?]
VaR (95%)[?]-10.18%[!]
|
CVaR (ES)[?]n/a[?]
Profit Factor (OOS)[?]0.57
|
Gain-to-Pain[?]-0.43
Trade Win Rate[?]n/a[?]
|
Expectancy (loss units)[?]-7%(of avg loss)
Period Win Rate (trades)[?]83%
|
Tail Ratio[?]n/a[?]
Payoff Ratio[?]0.12
|
Edge Stability (t)[?]-1.19
Skewness[?]-0.04
|
Kurtosis[?]2.07
Durbin-Watson[?]n/a[?]
|
Diagnostic: Payoff Ratio is very low (avg win is only a fraction of avg loss); gains are small relative to losses. Negative Recovery Factor indicates the strategy has not recovered from max drawdown and is net negative.
Context: OOS metrics from 1 window (N=53 returns) (small sample - interpret with caution).
Regime Context: High drawdown (Max DD: 36.6%). Consider regime-dependent risk; do not infer volatility expectations without explicit volatility estimate.
Tail Risk Profile: Moderate excess kurtosis (2.07) - heavier tails than normal. Skew: -0.04. Strategy is unprofitable or high drawdown; tail distribution is not the primary concern. Tail Ratio may be unreliable on small sample.
Tail Authority: CVaR (ES) is unreliable - insufficient sample for robust ES estimation (e.g. single OOS window). VaR is reported; CVaR is not. In degenerate tail cases ES would equal VaR; we do not report a ratio when CVaR is unavailable. Both VaR and any reported tail metrics should be treated as lower-bound estimates only.
Risk Attribution: High period win rate (83%) with Profit Factor < 1: winning periods are outweighed by larger losses in losing periods. Strategy is unprofitable despite many winning periods. Payoff Ratio (0.12) is very low - gains are small relative to losses.
Risk Verdict: Insufficient data - OOS metrics from 1 window are not statistically meaningful. Collect more walk-forward windows before interpreting.
❌ UNSTABLEInsufficient data - single OOS window. Collect more walk-forward windows before interpreting.Max Leverage: 1x

What Makes Kiploks Different

Most tools optimize performance.

Kiploks protects capital.

Why professionals use it:

  • • Walk-Forward as a first-class metric
  • • Parameter fragility detection
  • • Failure scenarios, not just ratios
  • • Honest capacity limits
  • • Explainable decision logic

No black boxes.

No “trust us”.

Who This Is For

Built for

Strategy development, testing, and deployment.

  • • Systematic traders
  • • Quant developers
  • • Small funds & prop desks
  • • Capital-aware professionals
  • • Bot and backtest builders

Not built for

  • • Signal sellers
  • • One-off backtesters
  • • “100% ROI” seekers

Frequently asked questions

What is Kiploks and what is it for?

Kiploks is an intelligent engine for analyzing trading strategies. We help traders and funds stress-test their trading ideas, measure the impact of slippage, and assess algorithm viability before going live.

How is Kiploks different from backtest platforms like QuantConnect?

Kiploks is not a backtester. It evaluates existing backtest and walk-forward results for robustness and survivability. Platforms like QuantConnect help you build and run backtests; Kiploks tells you whether those results are likely to hold up in live trading (overfitting, parameter fragility, capital risk).

What does the Kiploks Robustness Score mean?

The Kiploks Robustness Score is a 0-100 composite that reflects how well your strategy passes validation (walk-forward efficiency), risk (out-of-sample drawdowns), stability (parameter sensitivity), and execution (cost drag). A higher score means the strategy is more likely to survive real capital.

What is walk-forward analysis?

Walk-forward analysis splits history into rolling in-sample and out-of-sample windows. You optimize on in-sample and evaluate on out-of-sample to check if the edge carries over. Kiploks uses WFA results to compute Walk-Forward Efficiency (WFE) and other robustness metrics.

Why is the analysis free for now?

The project is in public beta. We believe quality analytics should be available to the community, and in return we rely on your feedback to make the system an industry standard.

What limits apply during beta?

Currently all users have Beta-limit: 100 (Promotional) — 100 full analytical reports per month. Need more? If you are a professional researcher or developer, contact support and we will increase your limit individually.

How accurate are the results?

The system uses complex nonlinear models to assess strategy degradation. However, as we are actively testing, technical errors or inaccuracies may occur. We constantly calibrate the engine but recommend using the data as a supporting tool, not as gospel.

What responsibility does Kiploks have for my trading results?

Important: Kiploks provides analytical data "as is". We do not accept liability for any financial losses, lost profit, or trading errors arising from our reports.

Trading on financial markets involves high risk. The decision to enter a trade or run an algorithm is always yours.

How can I help the project?

The best help is your feedback. If you spot a bug, odd numbers in a report, or have an idea for a new feature — get in touch. We are building this tool for you.

What integrations does Kiploks support?

We support Freqtrade: send backtest and Walk-Forward Analysis results to Kiploks for robustness stress-testing. Setup is Docker-native and requires no patches. See the [Freqtrade integration] page and the [kiploks-freqtrade repository] on GitHub.

For advanced topics (slippage sensitivity, Kill Switch, NOT VIABLE verdict), see the [Methodology FAQ].

Stop trusting backtests.

[Start evaluating survivability]

Kiploks - Trading Strategy Robustness Testing & Walk-Forward Validation